Tel Aviv - Delayed Quote ILA

Bonus BioGroup Ltd. (BONS.TA)

18.80
-0.20
(-1.05%)
At close: May 8 at 5:24:42 PM GMT+3
Currency in ILS All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Cost of Revenue
2,509
2,509
2,952
3,366
4,097
Gross Profit
-2,509
-2,509
-2,952
-3,366
-4,097
Operating Expense
25,327
25,327
26,838
33,681
60,638
Operating Income
-27,836
-27,836
-29,790
-37,047
-64,735
Net Non Operating Interest Income Expense
-254
-254
762
-615
-593
Pretax Income
-27,826
-27,826
-28,529
-38,703
-90,076
Net Income Common Stockholders
-27,826
-27,826
-28,529
-38,703
-90,076
Diluted NI Available to Com Stockholders
-27,826
-27,826
-28,529
-38,703
-90,076
Basic EPS
-0.04
-0.04
-0.05
-0.06
-0.16
Diluted EPS
-0.04
-0.04
-0.05
-0.06
-0.16
Basic Average Shares
624,423.87
624,423.87
623,334.80
623,167.59
579,121.17
Diluted Average Shares
624,423.87
624,423.87
623,334.80
623,167.59
579,121.17
Total Operating Income as Reported
-27,836
-27,836
-29,790
-37,047
-64,735
Rent Expense Supplemental
1,573
1,573
1,475
1,527
858
Total Expenses
27,836
27,836
29,790
37,047
64,735
Net Income from Continuing & Discontinued Operation
-27,826
-27,826
-28,529
-38,703
-90,076
Normalized Income
-27,805
-27,805
-28,529
-30,680
-69,258
Interest Income
543
543
1,641
293
0
Interest Expense
779
779
848
891
569
Net Interest Income
-254
-254
762
-615
-593
EBIT
-27,047
-27,047
-27,681
-37,812
-89,507
EBITDA
-24,254
-24,254
-24,920
-35,149
-88,031
Reconciled Cost of Revenue
2,509
2,509
2,952
3,366
4,097
Reconciled Depreciation
2,793
2,793
2,761
2,663
1,476
Net Income from Continuing Operation Net Minority Interest
-27,826
-27,826
-28,529
-38,703
-90,076
Total Unusual Items Excluding Goodwill
-21
-21
0
-8,023
-20,818
Total Unusual Items
-21
-21
0
-8,023
-20,818
Normalized EBITDA
-24,233
-24,233
-24,920
-27,126
-67,213
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 8/12/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BSFAF BSF Enterprise Plc
0.0584
0.00%
 
XUPB.F Genfit S.A.
3.7800
-0.53%
 
ABRT.CN Albert Labs International Corp.
0.0050
0.00%
 
688428.SS InnoCare Pharma Limited
20.56
+0.54%
 
6XC.F Soleno Therapeutics, Inc.
64.85
+1.25%
 
22Z.SG Zealand Pharma A/S
56.18
-6.30%
 
CSJA.F CSL Limited
66.50
0.00%
 
328.SG MeiraGTx Holdings PLC
4.8400
+0.83%
 
25I.SG ImmuPharma PLC
0.0295
0.00%
 
688068.SS Beijing Hotgen Biotech Co., Ltd.
109.40
-0.18%